FDA Inspection 1121677 — Labcorp Early Development Laboratories, Inc.
The FDA completed an inspection of Labcorp Early Development Laboratories, Inc. on Feb 14, 2020 in Madison, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 14, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Madison, WI (United States)
Additional Details
Bioanalytical BA/BE